title: [Efficacy of percutaneous coronary intervention in patients with ST elevation myocardial infarction and impaired glucose tolerance or diabetes mellitus].
abstract: OBJECTIVE
  To assess the role of percutaneous coronary intervention (PCI) for in-hospital and one-year prognosis of ST elevation (STE) myocardial infarction (MI) patients with impaired glucose tolerance (IGT) or type 2 diabetes mellitus (T2DM).
  
  
  METHODS
  This registry study included 601 STEMI patients admitted to hospital within 24 hours after STEMI onset during one year. According to medical history, dynamics of glycemia and results of oral glucose tolerance test patients were divided into 3 groups: (1) without disturbances of carbohydrate metabolism (DCM), (2) with IGT and (3) with T2DM. Primary PCI was performed in 373 (62.06%) patients while 228 (37.94%) received pharmacological treatment only. The following events were registered during one year after PCI: recurrent MI, stroke, admission for decompensated chronic heart failure (CHF), repeat emergency PCI.
  
  
  RESULTS
  Patients with IGT and DM compared with those without DCM had similarly more severe course of the index MI and worse one-year prognosis. PCI significantly improved one-year prognosis in patients with and without DCM.
  
  
  CONCLUSIONS
  Use of urgent PCI in STEMI patients with both DM and IGT is prognostically more beneficial in terms of lowering rate of adverse events during one year after MI.
authors.forename: Iu A
authors.initials: IuA
authors.lastname: Belen'kova
authors.forename: V N
authors.initials: VN
authors.lastname: Karetnikova
authors.forename: A O
authors.initials: AO
authors.lastname: Diachenko
authors.forename: O P
authors.initials: OP
authors.lastname: Blagoveshchenskaia
authors.forename: T S
authors.initials: TS
authors.lastname: Molodtsova
authors.forename: O L
authors.initials: OL
authors.lastname: Barbarash
mesh_terms: D050260:Carbohydrate Metabolism; D002317:Cardiovascular Agents / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D004562:Electrocardiography; D005260:Female; D005500:Follow-Up Studies; D018149:Glucose Intolerance / Q000150:complications*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000175:diagnosis / Q000453:epidemiology / Q000503:physiopathology / Q000628:therapy; D062645:Percutaneous Coronary Intervention / Q000009:adverse effects / Q000379:methods / Q000706:statistics & numerical data; D011183:Postoperative Complications / Q000453:epidemiology / Q000209:etiology / Q000503:physiopathology; D011379:Prognosis; D012042:Registries; D012307:Risk Factors; D012426:Russia / Q000453:epidemiology; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D002317:Cardiovascular Agents